If you missed the Cosmetic Ingredients Trade Show 2022 | In-Cosmetics Global in Paris, we at Sanobiotec are here to let you in on fascinating topics and trends regarding cannabinoids and their perspectives in the cosmetics industry which we gleaned in the fair. ... read more →
Tomas Kunstmonas, Head of Development at Sanobiotec, discusses the perspectives of rare cannabinoids, chemical synthesis advantages, and many other questions related to minor cannabinoids.... read more →
On November 3, Rytis V. Urbonas, co-founder of Sanobiotec, participated in a trade mission in Basel, Switzerland on Life sciences partnership opportunities: Innovative ecosystem co-creation with Lithuanian leaders. ... read more →
On September 24th, the Minister of the Economy and Innovation of the Republic of Lithuania, Aušrinė Armonaitė together with her team visited Sanobiotec. The meeting took place at Sanobiotec laboratory and HQ in Vilnius, Lithuania. ... read more →
Sanobiotec will participate in this year’s WHITE LABEL WORLD EXPO EUROPE, the international trade fair for thousands of the world's top suppliers, held on October 13-14 at the Messe Frankfurt, Germany. ... read more →
The updated site gives you more insights on minor cannabinoids and why we believe that these compounds have the potential to create value for our partners and the power to positively affect the lives of countless people around the world. ... read more →
FAST-growing Lithuanian business Sanobiotec aims to be a leading global player delivering on the potential of the many ‘minor’ cannabinoids, as Co-Founder Rytis Vincentas Urbonas explains.... read more →
Sanobiotec continues to push the limits of minor cannabinoid manufacturing technology, effectiveness, and compliance. In-house quality control and strict adherence to the highest manufacturing standards are crucial to the success and integrity of the entire cannabinoid industry.... read more →
Therapeutic use of cannabis is a growing industry increasingly accepted by the medical community and general public — but that growth may be stopped if biopharma companies lack reliable methods to extract and purify potentially useful compounds from the plant. ... read more →
Professor Edvinas Orentas, Department of Organic Chemistry, Vilnius University, Lithuania and Head of Research at Sanobiotec, discusses the stigma of synthetic cannabinoids in the Cannabis Science and Technology interview by Madeline Colli. Interview originally was published here.... read more →